Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.

导出 LinkOut

翻译打印收藏纠错

作者： Ashenafi,Bulle ^[1] ; Jeroen,Dekervel ^[1] ; Lise,Deschuttere ^[1] ; David,Nittner ^[2] ; Eric,Van Cutsem ^[3] ; Chris,Verslype ^[1] ; Jos,van Pelt ^[1]

作者单位： Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium. ^[1] Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium. ^[2] Department of Oncology, KU Leuven, Leuven, Belgium. ^[3]

关键词 GSEA Hif1α PDAC drug repurposing gene set enrichment analysis metabolic reprogramming pancreatic ductal adenocarcinoma tumor microenvironment

DOI 10.2147/OTT.S245134

PMID 32764982

发布时间 2022-04-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

OncoTargets and therapy

2020年13卷

6907-6916页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.

OncoTargets and therapy

相似文献

OncoTargets and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.

OncoTargets and therapy

相似文献

OncoTargets and therapy

相关期刊

检索历史清除